A drug, Keytruda, one of the world's most effective cancer medications, promises to transform treatment by delivering ...

A clinical trial showed that Lilly's weight loss medicine is superior to a key competitor's product. Eli Lilly (NYSE: LLY) is ...

In a major breakthrough for haemophilia care, the National Institute for Health and Care Excellence (NICE) has issued final draf ...

NICE is also looking at the role of Hympavzi in treating severe haemophilia A, where there are other subcutaneous options ...

In this randomized controlled trial, among men and gender-diverse persons who have sex with men, it was found that ...

Lilly is also developing oral therapies for its gastroenterology pipeline.

Topline data were announced from a phase 3 trial evaluating olezarsen in patients with moderate hypertriglyceridemia with or at risk for ASCVD.

Delcath Systems, Inc. (Nasdaq: DCTH) ("Delcath" or the "Company"), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, today announced full year 2025 ...

Genmab A/S announced today that it will present new research from its comprehensive development program evaluating its late-stage portfolio at the 2025 American Society of Clinical Oncology (ASCO) ...

Veronicah Muchina shells maize grain for her chickenA sloppy farm in Mairang’a village, Gatundu North, Kiambu county, reveals ...

"Identify the causes of cat vomiting after eating and learn evidence-based remedies. Expert guidance for cat owners to alleviate this health concern." ...